力生制药 (002393.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(力生制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,153,032,801.76911,572,469.80657,494,289.85335,604,291.001,146,589,384.58902,020,309.45614,740,089.46306,461,015.93
 营业利润(元) 419,805,685.72403,726,568.31104,938,530.2655,108,470.77118,064,533.25138,981,098.8988,631,708.9650,728,790.70
 利润总额(元) 420,214,331.79404,971,774.81106,034,296.2356,237,794.13118,364,462.58139,440,977.9689,084,689.4950,788,980.70
 净利润(元) 361,827,990.02342,666,216.1890,182,252.6746,500,336.4093,606,639.49112,623,728.9571,953,889.1141,953,999.32
 归属于母公司股东的净利润(元) 361,827,990.02342,666,216.1890,182,252.6746,500,336.4093,606,639.49112,623,728.9571,953,889.1141,953,999.32
盈利能力:
 销售毛利率(%) 59.4061.3062.0560.8157.5959.4060.4359.77
 销售净利率(%) 31.3837.5913.7213.868.1612.4911.7013.69
 净资产收益率(%) 7.827.522.041.05----
 总资产报酬率ROA(%) 6.516.701.661.01----
 投入资本回报率ROIC(%) 7.767.542.041.052.122.521.610.94
营运能力:
 存货周转率(次) 2.491.771.120.54----
 应收账款周转率(次) 14.174.783.071.56----
 总资产周转率(次) 0.210.170.120.06----
偿债能力:
 资产负债率(%) 15.1716.5317.0617.6417.8017.3817.2515.64
 股东权益比率(%) 84.8383.4782.9482.3682.2082.6282.7584.36
 已获利息倍数(倍) -6.04-9.89-4.97-23.25-0.76-1.32-2.67-8.77
 流动比率 4.504.263.943.593.603.143.464.10
 速动比率 4.203.993.613.233.282.773.053.63
发展能力:
 营业收入增长率(%) 0.561.066.959.515.007.944.67-6.45
 营业利润增长率(%) 255.57190.4918.408.63-13.7616.2017.9115.65
 税后利润增长率(%) 286.54204.2625.3310.84-23.3415.2617.4716.36
 净资产增长率(%) 12.743.82-0.94-0.86-1.392.082.002.65
 总资产增长率(%) 9.252.76-1.171.551.936.535.164.29

前瞻产业研究院